Auro Pharmacies Recalls Methyl-Cobalamin Injectable Due to Sterility Concerns
Auro Pharmacies, Inc. is recalling 90 vials of Methyl-Cobalamin injectable because inadequate processes and equipment were used to assure sterility.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II. According to the rubric, an FDA Class II recall involving a significant hazard such as lack of sterility assurance in an injectable product is rated as Severe (4).
Plain-English summary
Auro Pharmacies, Inc. is recalling 90 vials of Methyl-Cobalamin injectable, 5 mg/mL, 30 mL Multiple Dose vial. The product was distributed nationwide in the USA. The specific lot number is 180618/3, with an expiration date of 16-Sep-18.
The recall was initiated due to a lack of assurance of sterility. The source text states that inadequate processes and equipment were used to assure the sterility of products intended to be sterile. This is an FDA Class II recall.
Consumers and healthcare providers should stop using the affected product and contact Auro Pharmacies, Inc. for further instructions or a refund.
The recalled product
- Product
- Methyl-Cobalamin injectable, 5 mg/mL, 30 mL Multiple Dose vial, Rx only, Central Drugs Compounding Pharmacy, 520 W. La Habra Blvd, La Habra, CA 90631
- Manufacturer
- Auro Pharmacies, Inc.
- Category
- Drug — Injectable
- Hazard
- Affected units
- 90
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 180618/3
- Exp 16-Sep-18
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 12 recalled by Auro Pharmacies, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 12 products in this recall →Related recalls
Same manufacturer · Auro Pharmacies, Inc.
See all →- SevereAuro Pharmacies Recalls Folic Acid Injectable Due to Sterility Concerns
FDA (Drugs) · 2018-09-05
- SevereAuro Pharmacies Recalls Calcium Gluconate Injectable Due to Sterility Concerns
FDA (Drugs) · 2018-09-05
- SevereAuro Pharmacies Recalls Testosterone Injectable Due to Sterility Concerns
FDA (Drugs) · 2018-09-05
- SevereAuro Pharmacies Recalls Testosterone Enanthate/Cypionate Injectable Due to Sterility Concerns
FDA (Drugs) · 2018-09-05
- SevereAuro Pharmacies Recalls Glutathione Injectable Due to Sterility Concerns
FDA (Drugs) · 2018-09-05
Same hazard · sterility failure
See all →- SevereAvKare Carboxymethylcellulose Sodium Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereAvKare Carboxymethylcellulose Sodium Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereROHTO DIGI-EYE Eye Drops Recalled Over Sterility Assurance Gap
FDA (Drugs) · 2026-07-29
- HighROHTO DRY-AID Eye Drops Recalled Due to Sterility Concerns
FDA (Drugs) · 2026-07-29
- SevereOne-Piece Introducer Tray kits recalled for sterility failure
FDA (Devices) · 2026-07-22
Similar recalls
- SevereVitalab Methylcobalamin Injection Recalled Due to Sterility Concerns
FDA (Drugs) · 2018-05-16
- HighAxia Pharmaceutical Recalls Methylcobalamin Injection Due to Sterility Concerns
FDA (Drugs) · 2020-03-11
- SevereMethylcobalamin Injectable Recalled for Sterility Assurance Concerns
FDA (Drugs) · 2015-09-23
- SeverePromise Pharmacy Recalls Methylcobalamin Injections Due to Sterility Concerns
FDA (Drugs) · 2019-02-20
- SevereMethylcobalamin Injectable Recalled Due to Sterility Assurance Concerns
FDA (Drugs) · 2015-09-23
- SevereUS Compounding Recalls Methylcobalamin Vials Due to Sterility Assurance Concerns
FDA (Drugs) · 2015-11-25